Ohio Public Employees Retirement System (OPERS)’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,331
Closed -$169K 1989
2023
Q2
$169K Buy
+9,331
New +$148K ﹤0.01% 1401
2022
Q4
Sell
-5,500
Closed -$94K 1990
2022
Q3
$94K Buy
+5,500
New +$87.3K ﹤0.01% 1664

Other funds holding TARS

Ohio Public Employees Retirement System (OPERS)'s TARS Position: Q3 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Tarsus Pharmaceuticals (TARS) in Q3 2023, closing a stake of 9,331 shares — an estimated $169K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in TARS in Q3 2022 and held it in 2 quarters. The position peaked at $169K in Q2 2023. 105 funds tracked by Wall St. Rank hold TARS as of Q3 2023.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Tarsus Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 9,331 Tarsus Pharmaceuticals shares in Q3 2023, an estimated $169K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Tarsus Pharmaceuticals in Q3 2022 and held it in 2 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Tarsus Pharmaceuticals position peaked at $169K in Q2 2023.
  • 105 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q3 2023, filed 15 Nov 2023.